Publication:

Epstein–Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation

Thumbnail Image

Open/View Files

91343 14121.full.pdf (923.84 KB)

Date

2016

Authors

Published Version

10.1073/pnas.1616697113

Journal Title

Journal ISSN

Volume Title

Publisher

National Academy of Sciences
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Liang, Jun, Hufeng Zhou, Catherine Gerdt, Min Tan, Tyler Colson, Kenneth M. Kaye, Elliott Kieff, and Bo Zhao. 2016. “Epstein–Barr Virus Super-Enhancer ERNAs Are Essential for MYC Oncogene Expression and Lymphoblast Proliferation.” Proceedings of the National Academy of Sciences 113 (49): 14121–26. doi:10.1073/pnas.1616697113.

Abstract

Epstein-Barr virus (EBV) super-enhancers (ESEs) are essential for lymphoblastoid cell (LCL) growth and survival. Reanalyses of LCL global run-on sequencing (Gro-seq) data found abundant enhancer RNAs (eRNAs) being transcribed at ESEs. Inactivation of ESE components, EBV nuclear antigen 2 (EBNA2) and bromodomain-containing protein 4 (BRD4), significantly decreased eRNAs at ESEs -428 and -525 kb upstream of the MYC oncogene transcription start site (TSS). shRNA knockdown of the MYC -428 and -525 ESE eRNA caused LCL growth arrest and reduced cell growth. Furthermore, MYC ESE eRNA knockdown also significantly reduced MYC expression, ESE H3K27ac signals, and MYC ESEs looping to MYC TSS. These data indicate that ESE eRNAs strongly affect cell gene expression and enable LCL growth.

Description

Other Available Sources

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:41543056

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories